Analysts Offer Insights on Healthcare Companies: Addex Therapeutics (ADXN) and Belite Bio, Inc. ADR (BLTE)
Addex Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.
Addex Therapeutics analyst ratings
HC Wainwright Adjusts Addex Therapeutics' Price Target to $15 From $21, Keeps Buy Rating
Addex Therapeutics Price Target Cut to $15.00/Share From $21.00 by HC Wainwright & Co.
Addex Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Addex Therapeutics analyst ratings
HC Wainwright & Co. Maintains Buy on Addex Therapeutics, Lowers Price Target to $15
No Data